SCHEMBL4746018

SCHEMBL4746018

Cc1ccc2c(c1)c(-c1ccc3ncccc3c1)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
ADORA2A P29274 3/20 0.38
SRC P12931 4/20 0.38
PIK3CD O00329 2/20 0.38
ABL1 P00519 2/20 0.38
EGFR P00533 2/20 0.38
HCK P08631 2/20 0.38
KDR P35968 2/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CB P42338 2/20 0.38
MTOR P42345 2/20 0.38
PIK3CG P48736 2/20 0.38
EPHB4 P54760 2/20 0.38
PRKDC P78527 2/20 0.38
DYRK1A Q13627 1/20 0.38
TGFBR1 P36897 2/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746019 0.92 ALDH1A1 (0.44) ALDH1A1ADORA2ATGFBR1DHODHCCNC
SCHEMBL4746389 0.92 DHODH (0.34) ALDH1A1NPC1RAB9AABL1TGFBR1
SCHEMBL13320342 0.91 ALDH1A1 (0.45) ALDH1A1NPC1POLBRAB9AADORA2A
SCHEMBL4745812 0.91 ALDH1A1 (0.34) ALDH1A1ADORA2ASRCPIK3CDABL1
SCHEMBL4746387 0.91 DHODH (0.33) ALDH1A1NPC1RAB9ATGFBR1BACE1
SCHEMBL4746016 0.90 HSP90AA1 (0.37) ALDH1A1NPC1RAB9ASRCPIK3CD
SCHEMBL4746339 0.89 DHODH (0.36) ALDH1A1NPC1POLBRAB9ATGFBR1
SCHEMBL4746317 0.88 DHODH (0.35) ALDH1A1NPC1RAB9ADHODHKDM4E
SCHEMBL4746310 0.87 BCHE (0.34) ALDH1A1ABL1KDRDYRK1ATGFBR1
SCHEMBL4745912 0.86 TGFBR1 (0.31) TGFBR1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 ALDH1A1 179/4885NPC1 3564/4885POLB 2469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.